Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Cristina Alomar-Dominguez et al., published in Thrombosis Research, adding:
“In clinical practice, FXIII deficiency is therefore often overlooked during acute bleeding due to the limited availability of rapid FXIII assays and the inability of routine tests and standard viscoelastic methods to reliably detect reduced FXIII activity.
As a consequence, FXIII substitution is either delayed until laboratory results become available or omitted altogether, particularly within mass transfusion protocols which typically prioritize fibrinogen and prothrombin complex concentrate (PCC).”
Title: Defining a fibrinogen-to-factor XIII replacement ratio in an in-vitro model of dilutional coagulopathy
Authors: Cristina Alomar-Dominguez, Marie Therese Bauer, Dietmar Fries, Ludwig Deinhart, Jennifer Gebetsberger, Mirjam Bachler, Johannes Bösch, Wolfgang Schobersberger, Martin Hermann, Christian Irsara, Luca Brunelli, Anna Katharina Tobiasch
Find more posts featuring Ana Pedrero Gil on Hemostasis Today.
-
Jun 13, 2026, 18:25Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 18:21Thomas Stauch: Discussing the Future of ITP Research and Patient Care
-
Jun 13, 2026, 17:11Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
-
Jun 13, 2026, 16:21Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026